Medtech POV Blog

CMS Policy Update Breathes New Life into Care Options for Medicare Beneficiaries

  1. Scott Whitaker President & Chief Executive Officer
Read Full Op-ed
doctor consulting with senior patient

Last week, we celebrated an important CMS policy update: Under a new rule, called Medicare Coverage of Innovative Technology (MCIT), as soon as the FDA approves a new breakthrough technology – technologies that by definition treat life-threatening or irreversibly debilitating conditions and conditions for which there are no treatments or for which existing treatments are lacking – Medicare can cover that breakthrough technology.

Today, in an op-ed in Morning Consult, AdvaMed President and CEO Scott Whitaker encouraged the Biden administration to work with our industry to implement and strengthen the rule, saying, “Too many seniors’ lives depend on it.”

Scott explained, “This crucial change to federal law will leave the decision about whether a breakthrough medical technology is right for your grandfather precisely where it belongs: between your grandfather and his doctor. If it is the right choice, Medicare will pay for it; if it is not, then at least that medical technology is available through Medicare to other seniors who could benefit from it.”

Scott concluded his note with a direct appeal to President Biden: “We look forward to working with the Biden administration’s leaders at CMS to ensure that this bipartisan policy is here to stay.”

Read Full Op-ed

Related Content

Event / Regulatory Affairs

Medical Device Submissions Workshops – Premarket Approval (PMA)

8:30 am – 4:30 pm ET
February 6-7, 2025

Our in-depth device submissions workshops will provide real-world case studies, tips and best practices directly from FDA and industry experts.

Event / Regulatory Affairs

Medical Device Submissions Workshops – Investigational Device Exemption (IDE)

8:30 am – 5:15 pm ET
February 5, 2025

Our in-depth device submissions workshops will provide real-world case studies, tips and best practices directly from FDA and industry experts.

Event / China / Regulatory Affairs

China Regulatory Workshop

November 19, 2024 | 11:30 AM – 6:30 PM PT
November 20, 2024 | 8:15 AM – 4:00 PM PT

Get the latest on new policy updates and guidance for the clinical evaluation of medical devices.

Event / Regulatory Affairs

Medical Device Submissions Workshops – 510(k) and De Novo

8:30 am – 4:15 pm ET
February 3-4, 2025

Our in-depth device submissions workshops will provide real-world case studies, tips and best practices directly from FDA and industry experts.

News / Regulatory Affairs

Guardant Health’s Shield™ Blood Test Approved by FDA as a Primary Screening Option, Clearing Path for Medicare Reimbursement and a New Era of Colorectal Cancer Screening

July 31, 2024

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the U.S. Food and Drug Administration (FDA) has approved the company’s Shield™ blood test for colorectal cancer (CRC) screening in adults age 45 and older who are at average risk for the disease.

Event / Digital Health / Regulatory Affairs

AdvaMed Cybersecurity Summit

November 13, 2024
8:15 AM – 6:00 PM

Join us in Washington, D.C. for our Cybersecurity Summit that will address the future of medical device cybersecurity and changes in the industry landscape related to FDA requirements.

Resource / Regulatory Affairs

MedTech Reimbursement Playbook

July 17, 2024

Learn the basic principles of how medical technologies are covered and paid by insurers and the challenges medtech companies face.

Resource / Regulatory Affairs

Successful Market Access of SaMD & MDSW: Decoding the Confusion in MedTech Software Development

April 12, 2024

Artificial intelligence has been in the spotlight recently, but it is not a new concept to the Food and Drug Administration (FDA) or the medtech industry. AI advancements in the medtech industry are playing a major role in improving patients’ lives through innovative care, reduced healthcare costs, and improved patient outcomes.
View All

Medtech POV Podcast

Subscribe to Medtech POV with Scott Whitaker, a podcast covering the intersection of medtech and policy from every perspective.

Listen & Subscribe

Search